UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026399
Receipt number R000030332
Scientific Title Survey on integrative medicine utilization of Korean general people
Date of disclosure of the study information 2017/03/06
Last modified on 2020/08/02 11:20:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey on integrative medicine utilization of Korean general people

Acronym

Survey on integrative medicine utilization in Korea

Scientific Title

Survey on integrative medicine utilization of Korean general people

Scientific Title:Acronym

Survey on integrative medicine utilization in Korea

Region

Asia(except Japan)


Condition

Condition

General population

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the current state of integrated medical care in Korean people

Basic objectives2

Others

Basic objectives -Others

utilization study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Actual utilization

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants should be able to move cursors to read the screen freely.

Key exclusion criteria

None

Target sample size

1600


Research contact person

Name of lead principal investigator

1st name Ichiro
Middle name
Last name Arai

Organization

Nihon Pharmaceutical University

Division name

Kampo Pharmaceutical Sciences

Zip code

362-0806

Address

10281, Komuro, Ina, Kitaadachi, Saitama

TEL

048-721-1155

Email

ichiro.arai@nichiyaku.ac.jp


Public contact

Name of contact person

1st name Ichiro
Middle name
Last name Arai

Organization

Nihon Pharmaceutical University

Division name

Kampo Pharmaceutical Sciences

Zip code

362-0806

Address

10281, Komuro, Ina, Kitaadachi, Saitama

TEL

048-721-1155

Homepage URL


Email

ichiro.arai@nichiyaku.ac.jp


Sponsor or person

Institute

Devision of Kampo Pharmaceutical Sciences, Nihon Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Korea Instituate of Orientak Medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Nihon Pharmaceutical University

Address

10281, Komuro, Ina, Kitaadachi, Saitama, Japan

Tel

048-721-1155

Email

i-arai@nichiyaku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 06 Day


Related information

URL releasing protocol

https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-018-2294-6

Publication of results

Published


Result

URL related to results and publications

https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-018-2294-6

Number of participants that the trial has enrolled

1668

Results

An Internet survey on CAM was conducted for Koreans. In the past year, 67.9% were treated by doctors, 20.7% were treated by Korean Medical doctors, and 14.2% were not treated by anyone. In the CAMs received by doctors' prescriptions and advice, the ratio of Korean traditional medicine such as acupuncture and Korean medicine and health foods was high, and the use of other CAMs was low.

Results date posted

2020 Year 08 Month 02 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

General People in Korea

Participant flow

We collected 200 Korean from a tie-ups company of Anterio has over 500,000 panels.

Adverse events

none

Outcome measures

Korean version of International Questionnaire to measure use of CAM

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 01 Month 04 Day

Date of IRB

2017 Year 02 Month 21 Day

Anticipated trial start date

2017 Year 02 Month 24 Day

Last follow-up date

2017 Year 03 Month 10 Day

Date of closure to data entry

2017 Year 03 Month 10 Day

Date trial data considered complete

2017 Year 03 Month 10 Day

Date analysis concluded

2017 Year 03 Month 10 Day


Other

Other related information

Internet survey


Management information

Registered date

2017 Year 03 Month 04 Day

Last modified on

2020 Year 08 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030332


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name